Under the Revised National Tuberculosis Control Programme of India, patients with new smear-positive pulmonary tuberculosis are treated with a thrice-weekly regimen of antitubercular drugs for 6 months. The researchers conducted a retrospective analysis of the efficacy and tolerability of this regimen under clinical trial conditions in HIV-negative patients with newly diagnosed smear-positive pulmonary tuberculosis.
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/efficacy-6-month-thrice-weekly-regimen-treatment-new-sputum-smear-positive-pulmonary
[2] http://admin.indiaenvironmentportal.org.in/category/author/v-v-banu-rekha
[3] http://admin.indiaenvironmentportal.org.in/category/author/k-rajaram
[4] http://admin.indiaenvironmentportal.org.in/category/author/s-kripasankar-et-al
[5] http://admin.indiaenvironmentportal.org.in/category/journal/national-medical-journal-india
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/tuberculosis
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/chennai-d